Aya-Cross Country deal had ‘significant’ concerns identified by US FTC, agency says
MLex Summary: The US Federal Trade Commission identified “significant competitive concerns” in Aya Healthcare’s proposed acquisition of Cross Country Healthcare, according to Bureau of Competition Director Daniel Guarnera. The companies terminated...To view the full article, register now.
Already a subscriber? Click here to view full article